Literature DB >> 7632092

Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy.

Y Campos1, J Arenas, A Cabello, J J Gomez-Reino.   

Abstract

OBJECTIVE: To analyse muscle respiratory chain enzymes in idiopathic inflammatory myopathy.
METHODS: Four consecutive female patients seen at our hospital with idiopathic inflammatory myopathy were studied. Muscle histochemical staining included NADH tetrazolium reductase and succinate dehydrogenase tests. Activity of rotenone sensitive NADH cytochrome c reductase (complex I and III) succinate dehydrogenase (complex II), succinate cytochrome c reductase (complex II and III), cytochrome c oxidase (complex IV), and citrate synthase (a mitochondrial matrix enzyme), was measured spectrophotometrically in muscle homogenates. Free carnitine, and short and long chain acylcarnitine esters were determined in muscle homogenates by a radiochemical procedure.
RESULTS: Three patients had mitochondrial proliferation in nonregenerating muscle fibres; these patients had defects of respiratory chain enzyme complexes. Carnitine concentrations, measured in two of the four patients, revealed carnitine deficiency in one.
CONCLUSION: Our results suggest that mitochondrial dysfunction may be present in patients with inflammatory myositis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632092      PMCID: PMC1009908          DOI: 10.1136/ard.54.6.491

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Cytochrome c oxidase deficiency in Leigh syndrome.

Authors:  S DiMauro; S Servidei; M Zeviani; M DiRocco; D C DeVivo; S DiDonato; G Uziel; K Berry; G Hoganson; S D Johnsen
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

Review 3.  Mitochondrial encephalomyopathies.

Authors:  S DiMauro; C T Moraes
Journal:  Arch Neurol       Date:  1993-11

4.  Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency.

Authors:  S Di Donato; M Rimoldi; B Garavaglia; G Uziel
Journal:  Clin Chim Acta       Date:  1984-05-16       Impact factor: 3.786

5.  A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Authors:  L A Love; R L Leff; D D Fraser; I N Targoff; M Dalakas; P H Plotz; F W Miller
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

6.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases.

Authors:  N Zurgil; R Bakimer; H M Moutsopoulos; A G Tzioufas; P Youinou; D A Isenberg; M Scheinberg; T Kveder; B Rozman; C Luderschmidt
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

7.  A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis.

Authors:  S C Watkins; M J Cullen
Journal:  J Neurol Sci       Date:  1987-12       Impact factor: 3.181

8.  Polymyositis associated with asymptomatic primary biliary cirrhosis.

Authors:  Y Yasuda; S Nakano; I Akiguchi; M Tanaka; M Kameyama
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

9.  Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy.

Authors:  Y Campos; R Huertas; G Lorenzo; J Bautista; E Gutiérrez; M Aparicio; L Alesso; J Arenas
Journal:  Muscle Nerve       Date:  1993-02       Impact factor: 3.217

10.  Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy.

Authors:  Y Campos; R Huertas; J Bautista; E Gutiérrez; M Aparicio; G Lorenzo; D Segura; M Villanueva; A Cabello; L Alesso
Journal:  Muscle Nerve       Date:  1993-07       Impact factor: 3.217

  10 in total
  4 in total

1.  Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica.

Authors:  P Chariot; X Chevalier; M Yerroum; I Drogou; F J Authier; R Gherardi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

3.  Improved skeletal muscle fatigue resistance in experimental autoimmune myositis mice following high-intensity interval training.

Authors:  Takashi Yamada; Yuki Ashida; Katsuyuki Tamai; Iori Kimura; Nao Yamauchi; Azuma Naito; Nao Tokuda; Håkan Westerblad; Daniel C Andersson; Koichi Himori
Journal:  Arthritis Res Ther       Date:  2022-06-27       Impact factor: 5.606

4.  Idiopathic inflammatory myopathy human derived cells retain their ability to increase mitochondrial function.

Authors:  Carla Basualto-Alarcón; Félix A Urra; María Francisca Bozán; Fabián Jaña; Alejandra Trangulao; Jorge A Bevilacqua; J César Cárdenas
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.